This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Orthofix spends $6.1 million on FCPA work, nears deal with SEC

( October 31, 2016, 20:34 GMT | Official Statement) -- MLex Summary: Orthofix International, a Texas-based maker of orthopedic devices, said that it had spent $4.6 million in the second quarter of 2016 and $1.5 million in the third quarter on a Foreign Corrupt Practices Act case involving actions of foreign subsidiaries. Orthofix resolved the case with the US Department of Justice when its deferred prosecution agreement expired this summer, with the charges dismissed. Orthofix said it is still in discussions with the US Securities and Exchange Commission on the matter, although it cited an agreement in principle.Excerpt of SEC filing follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections